Cipher Surgical Seed
Founded 2010 · 10 employees on LinkedIn · 4 known investors
Find your way into Cipher Surgical Seed
Cipher Surgical develops the OpClear platform, a laparoscopic device that uses CO2 flow and on-demand saline lens washing to keep the endoscope lens clear during complex endoscopic and laparoscopic surgery. It is aimed at surgical teams to maintain continuous intra-abdominal vision, reduce scope removal events, and shorten operating times.
Founders & leadership
Cipher Surgical Seed was founded in 2010 by Andrew Newell.
AN
Andrew NewellinFounder and ChairmanAndrew Newell is a founder and chairman with approximately 30 years of experience building and scaling medical device companies across surgery, diagnostics, and critical care; he has led financings, established U.S. sales operations, and served in governance roles including chair, board positions, and venture capital investment.
MA
Mark AlleyPresident & CEO
Investors · 4
Frequently asked questions
- What does Cipher Surgical Seed do?
- Cipher Surgical develops the OpClear platform, a laparoscopic device that uses CO2 flow and on-demand saline lens washing to keep the endoscope lens clear during complex endoscopic and laparoscopic surgery. It is aimed at surgical teams to maintain continuous intra-abdominal vision, reduce scope removal events, and shorten operating times.
- Who founded Cipher Surgical Seed?
- Cipher Surgical Seed was founded by Andrew Newell in 2010.
- Who are Cipher Surgical Seed's investors?
- Cipher Surgical Seed's investors include Future Planet Capital, Midven Ltd., Venture Founders, Walking Ventures.